drug · small molecule
patient view →neratinib
Marketedupdated 2mo agoby $PBYI PUMA BIOTECHNOLOGY, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and 8 investigational indications.
targets
Epidermal growth factor receptorReceptor tyrosine-protein kinase erbB-2Receptor tyrosine-protein kinase erbB-4
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that